2020

1. A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

   International Journal of Gynecological Cancer, Vol. 30, Núm. 10, pp. 1633-1637